Related Experiment Video
Updated: Jun 21, 2026
03:55
Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
Papillary thyroid microcarcinomas: big decisions for a small tumor
Megan Rist Haymart1, Max Cayo, Herbert Chen
1Division of Metabolism, Endocrinology, and Diabetes (MEND), University of Michigan, Michigan, USA. meganhay@med.umich.edu
Annals of Surgical Oncology
|August 5, 2009
Summary
Management of papillary thyroid microcarcinoma (PTMC) is complex. This study found that larger tumor size and multifocality influence treatment decisions, while endocrine referral and younger age predict more aggressive interventions like radioactive iodine (RAI).
Area of Science:
- Endocrinology
- Oncology
- Surgical Pathology
Background:
- The clinical significance of papillary thyroid microcarcinoma (PTMC) remains debated, contributing to management challenges.
- Increasing incidence of PTMC necessitates a clearer understanding of treatment decision factors.
Purpose of the Study:
- To evaluate factors influencing treatment decisions for papillary thyroid microcarcinoma (PTMC).
- To analyze the relationship between patient/tumor characteristics and surgical intervention, endocrine referral, radioactive iodine (RAI) use, and levothyroxine (LT4) administration.
Main Methods:
- Retrospective analysis of 107 patients diagnosed with PTMC between 1994 and 2007.
- Evaluation of surgical intervention type, endocrinologist referral, RAI use, and LT4 administration.
- Multivariable logistic regression to identify predictive factors for treatment decisions.
Main Results:
- Multifocality and larger tumor size predicted total thyroidectomy.
- Larger PTMC size was associated with increased likelihood of endocrine referral.
- Multifocality, FNA diagnosis, larger size, and endocrine referral predicted RAI use.
- Total thyroidectomy and endocrine referral predicted suppressive LT4 doses.
- In low-risk PTMC (<0.8 cm), younger age predicted RAI administration.
Conclusions:
- Treatment decisions for PTMC begin during surgery, with endocrine referral indicating a more aggressive management approach.
- Younger patient age is a significant predictor for RAI administration in the lowest-risk PTMC cases.
